Frequent recovery and broad genotype 2 diversity characterize Hepatitis C virus infection in Ghana, West Africa

Journal of Virology

Volumn 77, Issue 14, 2003, Pages 7914-7923

  Candotti, Daniel ^a,d   Temple, Jillian ^b   Sarkodie, Francis ^c   Allain, Jean Pierre ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^d East Anglia Blood Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ANTIBODY SPECIFICITY; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CLUSTER ANALYSIS; GENETIC VARIABILITY; GHANA; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCREENING; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; UNINDEXED SEQUENCE; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD;

AMINO ACID SEQUENCE; BLOOD DONORS; GENOTYPE; GHANA; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREVALENCE; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

EID: 0038758948     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.14.7914-7923.2003     Document Type: Article

References (50)

1. Acquaye, J. K., and D. Tettey-Donkor. 2000. Frequency of hepatitis C virus antibodies and elevated serum alanine transaminase levels in Ghanaian blood donors. West Afr. J. Med. 19:239-241.
2. Agbodjan, E., M. Prince-David, T. Nicot, C. Dagnra, and F. Denis. 1995. Serologic and genomic research by PCR of hepatitis C virus in different populations in Lome (Togo). Bull. Soc. Pathol. Exot. 88:219-224.
3. Amoroso, P., M. Rapicetta, M. E. Tosti, A. Mele, E. Spada, S. Buonocore, G. Lettieri, P. Pierri, P. Chionne, A. R. Ciccaglione, and L. Sagliocca. 1998. Correlation between virus genotype and chronicity rate in acute hepatitis C. J. Hepatol. 28:939-944.
4. Ampofo, W., N. Nii-Trebi, J. Ansah, K. Abe, H. Naito, S. Aidoo, V. Nuvor, J. Brandful, N. Yamamoto, D. Ofori-Adjei, and K. Ishikawa. 2002. Prevalence of blood-borne infectious diseases in blood donors in Ghana. J. Clin. Microbiol. 40:3523-3525.
5. Basaras, M., A. Santamaria, M. Sarsa, E. Gutierrez, Y. de Olano, and R. Cisterna. 1999. Seroprevalence of hepatitis B and C, and human immunodeficiency type 1 viruses in a rural population from the Republic of Equatorial Guinea. Trans. R. Soc. Trop. Med. Hyg. 93:250-252.
6. Benvegnù L., P. Pontisso, D. Cavalletto, F. Noventa, L. Chemello, and A. Alberti. 1997. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 25:211-215.
7. Bigger, C. B., K. M. Brasky, and R. E. Lanford. 2001. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 75:7059-7066.
8. Candotti, D., A. Richetin, B. Cant, J. Temple, C. Sims, I. Reeves, J.A. Barbara, and J.-P. Allain. 2003. Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system. Transfusion 43:215-225.
9. Chan, S. W., F. McOmish, E. C. Holmes, B. Dow, J. F. Peutherer, E. Follett, P. L. Yap, and P. Simmonds. 1992. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73:1131-1141.
10. Combe, P., G. La Ruche, D. Bonard, T. Ouassa, H. Faye-Kette, F. Sylla-Koko, and F. Dabis; DYSCER-CI study group. 2001. Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Cote d'Ivoire, West Africa. Trans. R. Soc. Trop. Med. Hyg. 95:493-496.
11. Courouce, A. M., L. Noel, F. Barin, M. H. Elghouzzi, F. Lunel, M. L. North, and W. Smilovici. 1998. A comparative evaluation of the sensitivity of five anti-hepatitis C virus immunoblot assays. Vox Sang. 74:217-224.
12. Cramp, M. E., P. Carucci, J. Underhill, N. V. Naoumov, R. Williams, and P. T. Donaldson. 1998. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J. Hepatol. 29:207-213.
13. Dusheiko, G. M. 1992. Hepatocellular carcinoma in Africans. Ital. J. Gastroenterol. 24:146-147.
14. Farci, P., A. Shimoda, A. Coiana, G. Diaz, G. Peddis, J. C. Melpoder, A. Strazzera, D. Y. Chien, S. J. Munoz, A. Balestrieri, R. H. Purcell, and H. J. Alter. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344.
15. Freeman, A. J., G. Marinos, R. A. Ffrench, and A. R. LLoyd. 2001. Immunopathogenesis of hepatitis C virus infection. Immunol. Cell Biol. 79:515-536.
16. Hawkins, A., F. Davidson, and P. Simmonds. 1997. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay version 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J. Clin. Microbiol. 35:187-192.
17. Hwang S.-J., S.-D. Lee, R.-H. Lu, C.-W. Chu, J.-C. Wu, S.-T. Lai, and F.-Y. Chang. 2001. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J. Med. Virol. 65:505-509.
18. Jackson, P., J. Petrik, G. J. M. Alexander, G. Pearson, and J.-P. Allain. 1997. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma. J. Med. Virol. 51:67-79.
19. Jeannel, D., C. Fretz, Y. Traore, N. Kohdjo, A. Bigot, E. Pê Gamy, G. Jourdan, K. Kourouma, G. Maertens, F. Fumoux, J.-J. Fournel, and L. Stuyver. 1998. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J. Med. Virol. 55:92-97.
20. Journal of Viral Hepatology. 1999. Global surveillance and control of hepatitis C. Report of a W. H. O. Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J. Viral Hepat. 6:35-47.
21. Kenny-Walsh, E., and the Irish Hepatology Research Group. 1999. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N. Engl. J. Med. 340:1228-1233.
22. Kondili, L. A., P. Chionne, A. Constantino, U. Villano, C. Lo Noce, F. Pannozzo, A. Mele, S. Giampaoli, and M. Rapicetta. 2002. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 50:693-696.
23. Lanotte, P., F. Dubois, S. Le Pogam, C. Guerois, B. Fimbel, Y. Bacq, Y. Gruel, A. Goudeau, and F. Barin. 1998. The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs. J. Infect. Dis. 178:556-559.
24. Larghi, A., M. Zuin, A. Crosignani, M. L. Ribero, C. Pipia, P. M. Battezzati, G. Binelli, F. Donato, A. R. Zanetti, M. Podda, and A. Tagger. 2002. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 36:993-1000.
25. Laurent, C., D. Henzel, C. Mulanga-Kabeya, G. Maertens, B. Larouzé, and E. Delaporte. 2001. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. Int. J. Epidemiol. 30:872-877.
26. Lawal, Z., J. Petrik, V. S. Wong, G. J. Alexander, and J.-P. Allain. 1997. Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology 228:107-111.
27. Magierowska, M., I. Theodorou, P. Debre, F. Sanson, B. Autran, Y. Riviere, D. Charron, and D. Costagliola. 1999. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood 93: 936-941.
28. Memon, M. I., and M. A. Memon. 2002. Hepatitis C: an epidemiological review. J. Viral Hepat. 9:84-100.
29. Ndjomou, J., B. Kupfer, B. Kochan, L. Zekeng, L. Kaptue, and B. Matz. 2002. Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon. J. Med. Virol. 66:179-186.
30. Persico, M., E. Persico, R. Suozzo, S. Conte, M. De Seta, L. Coppola, B. Palmentieri, F. C. Sasso, and R. Torella. 2000. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology 118:760-764.
31. Prati, D., C. Capelli, A. Zanella, F. Mozzi, P. Bosoni, M. Pappalettera, F. Zanuso, L. Vianello, E. Locatelli, C. de Fazio, G. Ronchi, E. del Ninno, M. Colombo, and G. Sirchia. 1996. Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology 110:178-183.
32. Reid, A. E., and T. J. Liang. 1995. Association of hepatitis C virus and hepatocellular carcinoma in the United States. Princess Takamatsu Symp. 25:41-49.
33. Robertson, B., G. Myers, C. Howard, T. Brettin, J. Bukh, B. Gaschen, T. Gojobori, G. Maertens, M. Mizokami, O. Nainan, S. Netesov, K. Nishioka, T. Shin-i, P. Simmonds, D. Smith, L. Stuyver, and A. Weiner. 1998. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. Arch. Virol. 143: 2493-2503.
34. Ruggieri, A., C. Argentini, F. Kouruma, P. Chionne, E. D'Ugo, E. Spada, S. Dettori, S. Sabbatani, and M. Rapicetta. 1996. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J. Gen. Virol. 77:2073-2076.
35. Salemi, M., and A.-M. Vandamme. 2002. Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. J. Mol. Evol. 54:62-70.
36. Sarkodie, F., M. Adarkwa, Y. Adu-Sarkodie, D. Candotti, J. W. Acheampong, and J.-P. Allain. 2001. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sang. 80:142-147.
37. Takaki, A., M. Wiese, G. Maertens, E. Depla, U. Seifert, A. Liebetrau, J. L. Miller, M. P. Manns, and B. Rehermann. 2000. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nature 6:578-582.
38. Tanaka, E., and K. Kiyosawa. 2000. Natural history of acute hepatitis C. J. Gastroenterol. Hepatol. 15(Suppl.):E97-E104.
39. Tess, B. H., A. Levin, G. Brubaker, J. Shao, J. E. Drummond, H. J. Alter, and T. R. O'Brien. 2000. Seroprevalence of hepatitis C virus in the general population of northwest Tanzania. Am. J. Trop. Med. Hyg. 62:138-141.
40. Thimme, R., J. Bukh, H. C. Spangenberg, S. Wieland, J. Pemberton, C. Steiger, S. Govindarajan, R. H. Purcell, and F. V. Chisari. 2002. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl. Acad. Sci. USA 99:15661-15668.
41. Thomas, D. L., J. Astemborski, R. M. Rai, F. A. Anania, M. Schaeffer, N. Galai, K. Nolt, K. E. Nelson, S. A. Strathdee, L. Johnson, O. Laeyendecker, J. Boitnott, L. E. Wilson, and D. Vlahov. 2000. The natural history of hepatitis C virus infection: host, viral and environmental factors. JAMA 284:450-456.
42. Thursz, M. R., D. Kwiatkowski, C. E. Allsopp, B. M. Greenwood, H. C. Thomas, and A. V. Hill. 1995. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med. 332:1092-1093.
43. Tucker, T. J., M. Voight, A. Bird, S. Robson, B. Gibbs, J. Kannemeyer, M. Galloway, R. E. Kirsch, and H. Smuts. 1997. Hepatitis C virus infection rate in volunteer blood donors from the Western Cape - comparison of screening tests and PCR. S. Afr. Med. J. 87:603-605.
44. Van Dooren, S., E. Gotuzzo, M. Salemi, D. Watts, E. Audenaert, S. Duwe, H. Ellerbrok, R. Grasmann, E. Hagelberg, J. Desmyter, and A.-M. Vandamme. 1998. Evidence for a post-Columbian introduction of human T-cell lymphotropic virus in Latin America. J. Gen. Virol. 79:2695-2708.
45. Vardas, E., F. Sitas, K. Seidel, A. Casteling, and J. Sim. 1999. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia. Bull. W. H. O. 77:965-972.
46. Villano, S. A., D. Vlahov, K. E. Nelson, S. Cohn, and D. L. Thomas. 1999. Persistence of viraemia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29:908-914.
47. Vizmanos, J. L., C. J. Gonzalez-Navarro, F. J. Novo, M. P. Civeira, J. Pietro, A. Gullon, and M. Garcia-Delgado. 1998. Degree and distribution of variability in the 5′ untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV). J. Viral Hepat. 5:227-240.
48. Wansbrough-Jones, M. H., E. Frimpong, B. Cant, K. Harris, M. R. W. Evans, and C. G. Teo. 1998. Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans. R. Soc. Trop. Med. Hyg. 92:496-499.
49. + T cells in chronic hepatitis C virus infection. J. Immunol. 169:3447-3458.
50. Zein, N. N. 2000. Clinical significance of hepatitis C virus genotypes. Clin. Microbiol. Rev. 13:223-235.